Getting a new lab space? Design it for safety now and save thousands later

By Dan Scungio, MT (ASCP), SLS, CQA (ASQ)  bio Let me tell you a story. Once upon a time, there was a laboratory manager who worked in a hospital that was designing a new stand-alone … [Read more...]


5 ways to end generational stereotyping in your lab

By Dr. William A. Schiemann  bio These days, the Millennial Generation is hyped, perhaps even more than Baby Boomers were hyped in the 1950s and 1960s. As I meet with executives around the … [Read more...]


Genome Medical Bridges Genomic Testing, Medical Practice

Lisa Alderson, co-founder and CEO, Genome Medical Many well-known barriers are slowing the integration of genomic testing into routine clinical practice, including workforce shortages and a lack … [Read more...]


Testing Guidelines at a Glance

Evidence Lacking to Evaluate Celiac Screening The U.S. Preventive Services Task Force (USPSTF) found there is not enough evidence to advocate for or against screening asymptomatic adults, … [Read more...]


FDA Reports Progress in Advancing Regulatory Science for Diagnostics

The U.S. Food and Drug Administration (FDA) recently unveiled its FY 2015-2016: Regulatory Science Progress Report. The report, the second of its kind under the Food and Drug Administration Safety and … [Read more...]


Showing Test Prices May Not Change Ordering Behavior

Publishing testing prices in electronic ordering systems for inpatients may not lead to significant changes in clinician ordering behavior or associated fees, according to a study published April 21 … [Read more...]


Testosterone Testing Rises with DTC Ads

Televised direct-to-consumer advertising (DTCA) is associated with greater testosterone testing, according to a study published March 21 in the Journal of the American Medical Association. The … [Read more...]


Biomarkers Personalize PSA Screening

Early diagnosis of prostate cancer (PCa) is marred by a lack of consensus on the best screening strategy. Prostate specific antigen (PSA) had been in widespread use for routine PCa screening, until … [Read more...]


iSpecimen Generates New Market for Discarded Biospecimens

iSpecimen (Lexington, Mass.) can be thought of as a cross between a dating site and an online marketplace for human biospecimens. The company has built a turnkey solution that connects providers, such … [Read more...]


Do No Harm: Diagnostic Errors and the Lab

By Jennifer (McMahon) Dawson, MHA, DLM (ASCP)  bio "Do no harm" is the mantra that health care providers live by. Doctors, nurses and laboratory professionals alike enter into the business … [Read more...]